retatrutide clinical trial phase Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released 2 results demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished 🚨The first phase 3 retatrutide

For individuals interested in weight management, there are several MHRA-authorised and NICE-appraised options available in the UK that do not carry the uncertainties associated with unlicensed compounds

Coverage can vary widely depending on an individuals employer, plan type, and state regulations

Peppermint: Peppermint can help soothe the stomach

Best Practices: Coffee Guidelines During GLP-1 Treatment To safely enjoy coffee while on semaglutide, tirzepatide, or other GLP-1 medications, follow these evidence-based guidelines: (1) consume coffee with food or after eating a small protein-containing snack

Step 2: Remove the pen cap and inspect the medication through the viewing window

In the early 2020s, as GLP-1s became more popular, leading to shortages, doctors and patients began experimenting with stretching standard doses of Wegovy and Ozempic, which came in multidose injectable pens